Skip to content
Screener

Pacific Biosciences of California PACB Service and other revenue — Total Revenue

Other product segments

Consumable revenue
$20.11M+6.2%
Instrument revenue
$12.84M-9.3%

Similar metrics at other companies

ImmunityBio, Inc. logo
IBRXOther revenues — Total Revenue
$39K+388%
iRadimed logo
IRMDServices and other — Total Revenue
$1.04M+0.1%
Teradata logo
TDCServices and other — Total Revenue
$310M+7.3%
Everspin Technologies logo
MRAMEngineering services and other revenue — Total Revenue
$3.28M+188%
HQY
HQYService revenue — Total Revenue
$122.93M+2.6%
Idexx Laboratories logo
IDXXService revenue — Total Revenue
$474.7M+11.6%

Other financials

Income statement

See full
Revenue$39.0M-1.9%
Gross profit$12.6M-13.9%
Operating income-$44.6M+0.5%
Net income-$44.7M-6.7%
EPS (diluted)-$0.140.0%

Balance sheet

See full
Cash & equivalents$62.6M+10.5%
Total debt$61.8M+17.1%
Total equity-$33.2M-154%
Total assets$751.9M-8.9%

Cash flow

See full
Operating cash flow-$35.6M-21.1%
CapEx$1.6M+183%
Free cash flow-$37.1M-24.1%

Valuation

See full
Market cap$357.46M-5.6%
Enterprise value$356.64M-4.8%
P/S2.2×-0.2×

Profitability

See full
Gross margin36.4%+15.0pp
Operating margin-83.5%-37.4pp
Net margin-82.5%-35.5pp
FCF margin-77.5%-13.2pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio4.9×-2.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:30 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001299130-26-000122
(In thousands, except per share amounts)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue:
Product revenue$32,950$33,083$64,484$64,196
Service and other revenue6,0576,68311,70112,723
Total revenue39,00739,76676,18576,919
Cost of Revenue:
Cost of product revenue20,94420,02240,91646,355
Cost of service and other revenue5,2424,8539,4248,631
Amortization of acquired intangible assets1831833664,528

Item 1. Financial Statements (unaudited):

FAQ

What is Pacific Biosciences of California's service and other revenue — total revenue?
Pacific Biosciences of California (PACB) reported service and other revenue — total revenue of $6.06M in Q2 2026.
How has Pacific Biosciences of California's service and other revenue — total revenue changed year-over-year?
Pacific Biosciences of California's service and other revenue — total revenue decreased by 9.4% year-over-year, from $6.68M to $6.06M.
What does service and other revenue — total revenue mean?
This metric represents the total revenue generated from service contracts, maintenance agreements, and other ancillary support activities associated with the company's primary technology platforms. It reflects the recurring nature of the business model by capturing income derived from post-sale customer support and long-term service engagements. Growth in this area indicates a maturing installed base and increasing customer reliance on the company's technical infrastructure.

Ask your AI about Pacific Biosciences of California's service and other revenue — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude